chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Reports itching to face & arms beginning at 1224 Administered 25mg Diphenhydramine with relief. Cleared to leave at 1310 with reported improvement of itching.
Swelling at injection site that got worse a week after shot. 8 days later dull ache in full arm and hard, painfully, itchy  lump  at injection site. Pain in armpit (same arm as injection) started the same day as shot and continues to today (8 days later)
Soreness in R buttock. Palpable cystic mass deep into injection site C/W abscess. Given Rx for AUGMENTIN
w/this inj, had immed burning x 15min;@ ER visit pt presented 7cm circumference of erythema +ecchymosis to medial aspect of distal forearm (7mc x2cm); Disposition:Full Duty
got COVID; got COVID; 1st Dose Johnson Vaccine/ Booster Pfizer; booster; Selected Report Type: Initial Is report related to a study or programme? No Is the patient also the reporter? Yes Reporter type: Consumer or other non health professional Specify Consumer or other non health professional: mother  Primary / Prescribing Healthcare Professional Info HCP postal address: Regulatory Authority  Dates for got COVID: (From: Unspecified To: Unspecified) Reporter seriousness for got COVID: Unspecified  Is COVID vaccine a Pfizer product? Yes COVID vaccine manufacturer: Pfizer Dates for COVID vaccine: (Start: 11Nov2021 Stop: Unspecified) NDC number of COVID vaccine: Unknown Expiry Date of COVID vaccine: Unknown  Other Products: Not Provided Patient History: Not Provided Investigation Assessment: Not Provided  Additional Context: The report is cross referenced to report ID: (withheld) Warm transfer from withheld with Pfizer Medical Information-(withheld) The caller was fully vaccinated for COVID, and got COVID as well. She just had mild cold symptoms though. The caller got the Johnson Vaccine on 10Mar2021, with lot number 180522. Then, she got the Pfizer COVID booster. She got the booster on 11Nov2021 with lot number TH8030. She just had mild cold symptoms.  She got her vaccines at the health department. She did not have a prescribing doctor.   Is there a Product Complaint: Yes Description of Product Complaint: The caller was fully vaccinated for COVID, and got COVID as well. She just had mild cold symptoms though. The caller got the Johnson Vaccine on 10Mar2021, with lot number 180522. Then, she got the Pfizer COVID booster. She got the booster on 11Nov2021 with lot number TH8030. She just had mild cold symptoms. Patient got her vaccines at the health department. Just had mild cold symptoms though and did not have a prescribing doctor.  Follow-Up (11Jan2022): Follow-up attempts are completed. No further information is expected.
Information has been received from a physician concerning a female who was vaccinated with a dose of GARDASIL. Following vaccination, the patient experienced syncope. The patient sought a physician for medical attention. The patient recovered from syncope. Additional information has been requested.
Swollen lymph node in left armpit (Shot received in left arm). Slight pain in the area
Had pain at the injection site for 2.5 - 3 days only.  After 3 days I observed both my lymph nodes in my armpits were swollen and I felt very fatigued.  No real pain on lymph nodes just swollen.   Lasted for approximately 5 days and returned to normal around January 20th.  I am an athletic 37 year old male.  Had no illness prior.  Had telemedicine appointment with my doctor and he said to report the possible side effects.  Also had blood work up done at his requests to confirm everything was ?normal? with me.
REVERSIBLE ISCHEMIC NEUROLOGIC DEFICIT SYNDROME 11/11/2022 METABOLIC ENCEPHALOPATHY
Vaccine given 5/6. Mother states on 5/7 child couldn't walk. Next day could walk but had dry cough and nasal congestion. 5/9 stomach pain & earache. 5/11 child felt well.
Second Dose Vaccine Manufactured by Glaxo Smith Kline; Initial Report Received on 26-Oct-2021  A registered nurse reported that a 41 year-old female (race and ethnicity not provided) received HEPLISAV-B (hepatitis B vaccine) for the first dose of hepatitis B immunization and an adult hepatitis B vaccine manufactured by Glaxo Smith Kline for the second dose.   Medical history was reported as fatty liver, gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), migraine, anxiety, depression, herniated disc (cervical), chronic midline backpain, hepatic ulceration, and Biaxin (clarithromycin) allergy.  No relevant concomitant medications were reported.    On 07-Sep-2021, the patient received the first dose of HEPLISAV-B (Lot # 934967, expiration date 11-Apr-2022 and NDC # 4352800305) through an unknown route and site.   On 26-Oct-2021, the patient received the second dose of the hepatitis B vaccine series with an adult hepatitis B vaccine manufactured by Glaxo Smith Kline (Lot# P4DJ5 expiration date 15-Feb-2022) through an unknown route and site.  No additional information was reported.   Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
An expired Covid-19 pfizer vaccine was administered to the patient on 4/26/22.  The vaccine expired on 4/18/22 at 10am.  The error was discovered on 4/29/22. On 5/3, a COVID-19 Vaccine temperature related enquiry form was filled out and emailed to Pfizer.  On 5-9-22 at 7:51am, we received an email from Pfizer's quality team stating they do not have stability data to support our excursion from prescribed storage conditions. We have reached out to our affected patients informing them of the situation and offered to revaccinate them if they choose to. Spoke with patient on 5/10 and she will consider getting revaccinated.
experienced Covid-19 about 6 months after receiving the first dose; is  on the 6 months window and has not received the second dose yet; This case was reported by a physician via call center representative and described the occurrence of covid-19 in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, 6 months after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced covid-19 and incomplete course of vaccination. On an unknown date, the outcome of the covid-19 and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the covid-19 to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported for 1st dose. The age at vaccination was not applicable for 2nd dose. The patient had Covid-19 about 6 months after receiving the first dose of Shingrix. The patient was on the 6 months window and had not receive the second dose yet. Till the time of reporting, the patient did not received 2nd dose which led to incomplete course of vaccination. The VAERS details were not applicable for 2nd dose of Shingrix vaccine. No other patient or vaccine data was provided. The reporter consented to follow up
This spontaneous report was received from a physician refers to a patient of unknown age and gender. On 08-JUN-2015, the patient was vaccinated with improperly stored PROQUAD (Merck) lot # K025766, expiry date 08-JUN-2015. This is one of the several reports received from the same reporter. Additional information has been requested.
RPH on duty incorrectly mixed the vaccine incorrectly. Instead of using a new vial of vaccine and adding 1.8ml of Sodium Chloride 0.9%, he accidently used a used vial of little to no vaccine and added 1.8ml of NACL 0.9%  and drew up 6 shots of this.  Therefore, patient got Sodium Chloride instead of the actual vaccine. However, the mistake was caught early and patient was able to come back the same day to get revaccinated with the correct dose of the vaccine. No adverse reaction reported as of 4/29/21.
This spontaneous report was received from a registered nurse referring to a patient of currently 62 years of age and unspecified gender. The patient's pertinent medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated with improperly stored dose of ZOSTAVAX, lot # L027322, expiry date unspecified (dose, route of administration and anatomical location not reported). The doses of ZOSTAVAX was involved in temperature incident. This is one of several reports from the same reporter. Additional information has been requested.
Injection site pain, tiredness, headache, muscle pain, joint pain, fever, feeling unwell, and decreased appetite. Asprin, Acetaminophen, Ibuprofen and lots of bed rest and sleep. 36 hours later all is well. just a little injection site pain remains.
No additional adverse event were reported; Office manager reported that a patient received an improperly stored VARIVAX that was reconstituted with properly stored sterile diluent; This spontaneous report has been received from office manager, regarding a patient of unknown gender and age.   The patient's concurrent conditions, medical history and concomitant therapies were not reported   On 11-APR-2022, the patient was vaccinated with first dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot # U025791 has been verified to be valid, expiration date 19-AUG-2023) (dose regimen, route of administration and anatomical location were not reported), reconstituted with properly stored Merck sterile diluent (lot# and expiration date were not provided) administered for prophylaxis.   It was reported that the varicella virus vaccine live (oka/merck) (VARIVAX) underwent a temperature excursion of 6 Fahrenheit (°F) up to 14 °F for 15 minutes and 14 °F up to 46 °F (average temperature 34.93 °F) for 1 hours and 15 minutes (product storage error). There was no previous temperature excursion. Not adverse events (AE) were reported, and no further information was provided.
3/22/2021 Mon injection  site hurts 1 pm tired  3/23/2021 Tues injection site hurts  3/24/2021 Wed 9am stomach upset 11am left side lower neck lymph nodes swelling 2pm diarrhea  5pm left and right lymph nodes  lower neck pain and swelling 9pm right and left lymph nodes under ears swelling  3/25/2012 Thur  7am lymph  nodes  still swelling  , congestion,  9am upset stomach  tired,  3:20 zoom meeting with doctor  have appointment 3/26/2021 for covid test and Streep test.
Immediate vasovagal response. States this is common with shots or blood draws. BP dropped as low as 63/37 and HR was 47; 98% RA. Upon awakening, which was instant, he was diophretic but alert. He was able to take food and water and recovered his BP to 112/73, HR 62; 98% RA.
itching at the injection site; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 62 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 62 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PRURITUS (non-serious), outcome "unknown", described as "itching at the injection site".  Additional information: I have itching at the injection site, and I would like to know if that is normal or is that is an allergic reaction. Received call from consumer regarding the Pfizer COVID vaccine. She has itching where she got the shot at.  She would like to know if this is normal or does this mean she is having an allergic reaction.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
20 minutes after administering, patient complained of hives and itching.  Benadryl was administered.  30 minutes after administration, patient complained that throat was closing up and having difficulty breathing.  EpiPen was administered in right thigh and paramedics call.  Paramedics accessed patient and patient refused to go to hospital.  Patient left facility on their own.
Fever developed within 5hours. Body aches, lack of appetite, fatigue and fever lasted until Tuesday April 6 when fever broke. Fever was as high as 100.3* but did not sustain at that temp the entire time. Range of 99.1*- 100.3* varied throughout the days.  Sleep and ibuprofen were used to deal with effects. Did not take prescribed meds regularly during this week as I forgot, or was sleeping during dosage times.
cramps in his legs in weird places; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 70-year-old male patient received BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration on 22Apr2021 as 1st dose, single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On unspecified date of Apr2021 (reported as a day or two later), the patient experienced cramps in his legs in weird places. The outcome of the event was not recovered.  Information about batch no/lot no has been requested.
Pt was given bexero followed by a pfizer covid-19 booster in the right arm while sitting on the exam table. Her body went flaccid and she became unresponsive to verbal stimuli instantly following the covid booster. I was able to catch the pt and safely guide her to a supine position on the table. Pt postured and began having tonic clonic activity in her eyes, arms, and legs. I called for Dr. assistance. Dr. responded to the room and began an examination. I got the pt's legs elevated for proper blood flow. After several seconds, pt was able to start rousing. Blood pressure and pulse both within normal limits at this time. Pt was given juice and water. Pt stayed supine with legs elevated for approximately 20 minutes. Pt then was instructed to lower her legs. Pt remained this way for several minutes. I then increased the incline in small increments, giving her several minutes to adjust after each increase. Once at 90 degrees pt was instructed to let legs dangle from the table. At this point pt reported feeling back to normal. Dr.  examined pt once more and gave the ok to stand. Pt stood for several minutes and after reporting that she felt back to normal was deemed safe to leave clinic. Pt was monitored constantly by clinic staff, from the start of the episode until deemed safe to leave clinic by Dr. The concludes my report. Report given and by the time I arrived in the room patient was lying supine on table with knees bent with fluttering of eyelids noted but no tonic clonic activity or posturing. Within 5 seconds she opened her eyes and responded to her name and asked if she passed out. She then appropriately answered questions for the remainder of the time. I suspect she had a vasovagal episode with associated tonic-clonic activity due to brief anoxia given she did not have a post-ictal period and given she reported feeling lightheaded right before the event (but did not verbalize this at the time). Given the immediate nature of the syncope, will report to VAERS, but discussed with patient this appeared more consistent with vasovagal response and would be ok with her receiving future doses under close supervision.
I began to get increased inflammation and I went to my rheumatologist who gave me shots of a steroid for the inflammation. The provider indicated that this could be my new normal. I began to take both Meloxicam and Embrel. Things got better with the Meloxicam so I took the booster vaccine which intensified the inflammation. Even the bottoms of my feet hurt. My heart rate would get high for no reason, then return to normal, The swelling continued coming and I developed a Venus leg ulcer that was bleeding thru my leg. It was small vein and it came right thru. I received Sclerotherapy but that has still not worked. The vein is still not healing. The third dose booster information is Pfizer-FE3594 administered on 12-08-2021.
STATUS EPILEPTICUS 3/20/2023 APHASIA, LATE EFFECT OF EMBOLIC STROKE
About a week after the second dose, I had a flare up of sciatica pain which immobilized me for four months.  Simultaneously, I stopped having solid bowel movements, and had diarrhea which has lasted for six months. I have not had one single solid bowel movement.
13Feb91 to Pvt MD for inc fever-which rebounded when off Tylenol. DX: ear infection, antibiotics given-MD felt not related to vax-30Feb91 4pm, went to ER due to recurrent T, antibiotic changed, 27FEB91 to MD, repeated antibiotic for ears
I have a rash that has many characteristics.  On my face it is like a sheet, on my arm it is a red itchy rash, slightly raised on a finger it is raw and oozing and on my leg it is red and breaking the; On my face it is like a sheet, on my arm it is a red itchy rash, slightly raised on a finger it is raw and oozing and on my leg it is red and breaking the skin.; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 14Mar2021 at 10:30(at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included hairy cell leukemia. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 14Feb2021 at 11:00(at the age of 62-year-old) as a single dose for COVID-19 immunisation. On 19Apr2021 at 16:15, the patient experienced had a rash that had many characteristics. On the face it had like a sheet, on the arm it had a red itchy rash, slightly raised on a finger it is raw and oozing and on the leg it had red and breaking the skin. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of a rash that had many characteristics. On the face it is like a sheet, on the arm it is a red itchy rash, slightly raised on a finger it is raw and oozing and on the leg it red and breaking the skin and included treatment with washing, rubbing alcohol and Benadryl. On 20Apr2021, the patient underwent saliva test and the result was negative. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events, had a rash that had many characteristics, On the face it like a sheet, on the arm it had a red itchy rash, slightly raised on a finger it had raw and oozing and on my leg it red and breaking the skin was recovering at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Patient says she experienced low grade fever with chills with localized swelling and inflamamation lasting 72 hours.  Patient seen today (08/17/2015) by Dr.
Severe fever 103.1, chills, fatigue, severe headaches, nausea, swelling of arm from tricep to inside of bicep which made skin tight, severe pain if touched also, itchiness, dizziness.
I started getting nauseous. I didn't throw up though. I got hot and feverish. Had hot, red chicks and tingling. I felt tired like a zombie, chills, muscle cramps, diarrhea, and joint pain. Also, had a massive headache
Two days after the vaccines my daughter was sent home from daycare with a 102 fever and lethargy. Shortly after her fever reduced, she starting developing hives on her wrists, back and legs over the next couple of days. I contacted our physician's office on Aug 28th because some of the hives started to become quite large (3 + inches) and they recommended BENADRYL. Nothing new was added to her diet and no other known contributing factors besides the vaccines earlier in the week.
Left upper thigh is a half dollar sized area of erythema that is not warm or tender to the touch.
memory loss; it was strange feeling; hard time to concentrate; headache; This spontaneous case was reported by a consumer and describes the occurrence of AMNESIA (memory loss), FEELING ABNORMAL (it was strange feeling), DISTURBANCE IN ATTENTION (hard time to concentrate) and HEADACHE (headache) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Stroke. Concurrent medical conditions included Hypothyroidism, Hypertension, Overweight and Arrhythmia. Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] and ASCORBIC ACID, ERGOCALCIFEROL, NICOTINAMIDE, RETINOL, RIBOFLAVIN, THIAMINE HYDROCHLORIDE (VITAMINS [ASCORBIC ACID;ERGOCALCIFEROL;NICOTINAMIDE;RETINOL;RIBOFLAVIN;THIAMINE HYDROCHLORIDE]) for an unknown indication.    On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced AMNESIA (memory loss), FEELING ABNORMAL (it was strange feeling), DISTURBANCE IN ATTENTION (hard time to concentrate) and HEADACHE (headache). On 07-Mar-2021, AMNESIA (memory loss), FEELING ABNORMAL (it was strange feeling) and HEADACHE (headache) had resolved. At the time of the report, DISTURBANCE IN ATTENTION (hard time to concentrate) outcome was unknown.            No treatment drugs were reported.
Patient experienced swelling, heat, redness, and itching at the injection site. She had a faded handprint-sized area on the upper arm at the 7 day mark today. The heat and itching are not listed as common side effects in the literature, hence this report.
Patient experienced symptoms 45 minutes after influenza vaccination, develped right sided arm, shoulder, neck, face and jaw weakness and stiffness. Jaw began to spasm and "lock up". He states he experienced right eye redness and ptosis. Injection was in right deltoid. Symptoms lasted about 24 hours.
The month following my second dose on  04/08/2021 I skipped my menstrual cycle (May). Then it returned in June, then I skipped July and August. It returned once again in September, then I haven?t had it again since and it is now February but I am not pregnant.
6PM pt began to cry; had swelling & red areas over upper red thigh; cried for about 3-3 1/2 hrs; called MD prescribed DPH & APAP & cold cloth which relieved sx; swelling went down by next early AM;
tested positive for COVID 19 on 30Jan2021; she was not feeling well; This is a spontaneous report from a contactable consumer (patient's daughter-in-law). A 65-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 25Jan2021 (Batch/Lot number was not reported) at age of 65 years old as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient got the first dose of the Pfizer COVID 19 vaccine on 25Jan2021; then on 26Jan2021 she was not feeling well; and then tested positive for COVID 19 on 30Jan2021. The patient was scheduled to receive the next dose of the vaccine 13Feb2021. Consumer was asking if her mother-in-law should reschedule the second dose of the vaccine because her quarantine will only be up on 12Feb2021. The outcome of events was unknown.    This is also being submitted to notify that the batch number is not available despite the follow-up attempts made.  Follow-up attempts have been completed and no further information is expected.